Good morning folks,
Well the big day is finally here and this afternoon we will know if we get our first rate increase in nearly a decade. The markets held up surprisingly well heading into the big decision. Heading into the decision the market will likely be slow and choppy. After the announcement the first reaction is typically a head fake while people digest the full statement and the impact it has>>>so be on your toes.
We have options expiration this week so the next day and a half could get extremely volatile, play close attention to the VIX. There may be some scalp opportunities in TVIX and UVXY. GOLD and OIL had a fairly nice bounce yesterday while the strength of the dollar struggled. A Fed raise should strengthen the dollar and commodities should weaken but what really matters is how hawkish or dovish the Fed statement is moving forward. Janet Yellen has a news conference 30 minutes after the announcement and what she says in that conference will help the markets determine the tone.
Bullish and may have lottos in play
Cautiously optimistic
Very Cautious may even present a short opportunity
07:35:31am
09/17/15 |
Aeri Pharma +90% Following Wednesday Announcement Rhopressa Phase 3 Trial Achieved Primary Endpoint
|
AERI is today's ICTI (which is also gapping) the difference is the balance sheet and the size of the short position This could be a squeezer do not chase it look for and intraday setup likely going to raise capital
07:25:50am
09/17/15 |
Can-Fite +37% Premarket Following Announcement of FDA Fast Track Designation for CF102 in Treatment of Liver Cancer
|
Gapper can be a pop and flopper thin float don't chase it likely needs to raise cash soon if it gaps too much likely a better short
No dollar amount attached to the pr its been pulling back since crossing the 5 dolla holla would like to see it continue flagging out on the daily Very thin stock looking to get back in it with another swing ideally around 4 but it may not get there
07:39:45am
09/17/15 |
TG Therapeutics Announces Special Protocol Assessment Agreement With the FDA for the First Phase 3 Clinical Trial of Its Proprietary Combination Regimen of TG-1101 in Combination With TGR-1202 for Patients With Chronic Lymphocytic Leuke
|
08:01:01am
09/17/15 |
Inovio Pharmaceuticals Publishes Successful Phase 2b Trial Results of Its HPV Immunotherapy in The Lancet
|
08:41:00am
09/17/15 |
WaferGen +19% Premarket; Was Scheduled to Present New Single-Cell System Results at the Single Cell Genomics Meeting in The Netherlands on Wednesday
|
Gapping premarket low volume delayed reaction to yesterdays pr worth watching for a 2 roll
08:05:59am
09/17/15 |
AEON, Authentidate Launch Cancer Genetic Testing With Telehealth-Based Genetic Counseling
|
Recent IPO could be puttin in a bottom small float needs cash soon would consider it for a scalp trade


No comments:
Post a Comment